Literature DB >> 29224938

Subclinical Atherosclerosis in Pediatric Liver Transplant Recipients: Carotid and Aorta Intima-Media Thickness and Their Predictors.

Emily R Perito1, Andrew Phelps2, Tabitha Vase3, Vickie A Feldstein2, Robert H Lustig4, Philip Rosenthal5.   

Abstract

OBJECTIVE: To investigate prevalence and predictors of cardiovascular risk in pediatric liver transplant recipients using noninvasive markers of subclinical atherosclerosis: carotid intima-media thickness (cIMT) and aorta intima-media thickness (aIMT). STUDY
DESIGN: Cross-sectional study of 88 pediatric liver transplant recipients. The cIMT and aIMT were measured by ultrasound imaging using standardized protocol.
RESULTS: Participants were 15.4 ± 4.8 years of age, and 11.2 ± 5.6 years post-transplantation. The cIMT and aIMT were both higher in males than females. In analyses adjusted for sex, age, and height, the cIMT was higher in subjects transplanted for chronic/cirrhotic liver disease and lower in subjects on cyclosporine (n = 9) than tacrolimus (n = 71). The cIMT was not associated with rejection history or current corticosteroid use. The cIMT increased with increasing diastolic blood pressure and triglycerides. The aIMT (n = 83) also increased with age, and its rate of increase post-transplant varied by age at transplantation. In adjusted analyses, aIMT was higher in subjects with glucose intolerance. In analysis of patients ≤20 years of age for whom blood pressure percentiles could be calculated (n = 66), aIMT increased with increasing diastolic blood pressure percentile (0.010 mm per 5-percentile; 95% CI, 0.000-0.021; P = 0.05). Neither the cIMT nor the aIMT was associated with obesity, systolic hypertension, or other dyslipidemia at study visit.
CONCLUSION: Measures of long-term cardiovascular risk were associated with conditions that are more common in pediatric liver transplant recipients than nontransplanted peers, namely, diastolic hypertension and glucose intolerance. Larger, longitudinal studies are warranted to investigate whether cIMT could be useful for stratifying these patients' cardiovascular risk-and potential need for proactive intervention-during long-term follow-up.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atherosclerosis; cardiovascular risk; children; liver transplantation; metabolic syndrome

Mesh:

Substances:

Year:  2017        PMID: 29224938      PMCID: PMC5794603          DOI: 10.1016/j.jpeds.2017.10.006

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  34 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

3.  Evaluation of risk for atherosclerosis in Alagille syndrome and progressive familial intrahepatic cholestasis: two congenital cholestatic diseases with different lipoprotein metabolisms.

Authors:  Hironori Nagasaka; Tohru Yorifuji; Hiroto Egawa; Hidekatsu Yanai; Tomoo Fujisawa; Kiyotaka Kosugiyama; Akira Matsui; Makoto Hasegawa; Tomoo Okada; Masaki Takayanagi; Hitoshi Chiba; Kunihiko Kobayashi
Journal:  J Pediatr       Date:  2005-03       Impact factor: 4.406

Review 4.  Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.

Authors:  Henry C McGill; C Alex McMahan; Samuel S Gidding
Journal:  Circulation       Date:  2008-03-04       Impact factor: 29.690

5.  Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

Authors:  Deirdre A Kelly; John C Bucuvalas; Estella M Alonso; Saul J Karpen; Upton Allen; Michael Green; Douglas Farmer; Eyal Shemesh; Ruth A McDonald
Journal:  Liver Transpl       Date:  2013-08       Impact factor: 5.799

Review 6.  Risk factors for metabolic syndrome after liver transplantation: A systematic review and meta-analysis.

Authors:  Line Buch Thoefner; Andreas Arendtsen Rostved; Hans-Christian Pommergaard; Allan Rasmussen
Journal:  Transplant Rev (Orlando)       Date:  2017-04-23       Impact factor: 3.943

7.  Lipid profile and cardiovascular risk factors in pediatric liver transplant recipients.

Authors:  Emilie Roblin; Jérôme Dumortier; Mathilde Di Filippo; Sophie Collardeau-Frachon; Agnès Sassolas; Noël Peretti; André Serusclat; Christine Rivet; Olivier Boillot; Alain Lachaux
Journal:  Pediatr Transplant       Date:  2016-01-11

Review 8.  Subclinical cardiovascular changes in pediatric solid organ transplant recipients: A systematic review and meta-analysis.

Authors:  Yasser Al Nasser; Marta C Moura; Luc Mertens; Brian W McCrindle; Rulan S Parekh; Vicky L Ng; Peter C Church; Marialena Mouzaki
Journal:  Pediatr Transplant       Date:  2016-02-18

Review 9.  Intima media thickness measurement in children: A statement from the Association for European Paediatric Cardiology (AEPC) Working Group on Cardiovascular Prevention endorsed by the Association for European Paediatric Cardiology.

Authors:  Robert Dalla Pozza; Doris Ehringer-Schetitska; Peter Fritsch; Eero Jokinen; Andreas Petropoulos; Renate Oberhoffer
Journal:  Atherosclerosis       Date:  2014-12-24       Impact factor: 5.162

10.  Risk factors associated with aortic and carotid intima-media thickness in adolescents and young adults: the Muscatine Offspring Study.

Authors:  Jeffrey D Dawson; Milan Sonka; Mary Beth Blecha; Wenjiao Lin; Patricia H Davis
Journal:  J Am Coll Cardiol       Date:  2009-06-16       Impact factor: 24.094

View more
  1 in total

Review 1.  Current applications for measuring pediatric intima-media thickness.

Authors:  Ramy El Jalbout; Emile Levy; Yves Pastore; Prevost Jantchou; Chantale Lapierre; Josée Dubois
Journal:  Pediatr Radiol       Date:  2022-01-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.